Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL
Clinical trial NCT03707847 · UNKNOWN
Trial details
- NCT number
- NCT03707847
- Sponsor
- Mingzhi Zhang
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2020-02-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.